INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Alkem Laboratories Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 539523	ISIN Demat INE540L01014	Book Value 1,142.87	NSE Symbol ALKEM	Dividend Yield (%) 0.8	Market Cap (₹ Cr.) 67,331.83	P/E 30.11	EPS 187.01	Face Value 2

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	8,813.44	7,963.85	9,054.55	8,829.81	7,219.68
Sale of Products	8,653.65	7,734.77	8,894.16	8,710.06	7,088.08
Sale of Services	0.00	0.00	0.00	0.00	0.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	159.79	229.08	160.39	119.75	131.60
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	8,813.44	7,963.85	9,054.55	8,829.81	7,219.68
Other Income	507.06	305.99	266.29	199.89	190.01
Total Revenue	9,320.50	8,269.84	9,320.84	9,029.70	7,409.69
Changes in Inventories	56.61	-30.85	257.73	-360.90	-301.29
Cost of Material Consumed	2,395.92	2,270.36	2,629.78	2,849.75	2,046.52
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	389.61	384.27	943.13	1,077.04	919.79
Employee Benefits	1,630.96	1,478.01	1,516.22	1,434.49	1,158.72
Total Other Expenses	2,184.14	2,190.88	2,330.74	2,019.07	1,447.01
Manufacturing / Operating Expenses	720.62	628.94	559.93	592.58	422.64
Administrative and Selling Expenses	1,569.35	1,542.70	1,667.22	1,375.55	965.41
Other Expenses	-105.83	19.24	103.59	50.94	58.96
Finance Costs	76.11	80.07	86.40	37.90	42.93
Depreciation and Amortization	283.61	239.14	229.85	218.98	198.93
Total Expenses	7,016.96	6,611.88	7,993.85	7,276.33	5,512.61
Profit Before Exceptional Items and Tax	2,303.54	1,657.96	1,326.99	1,753.37	1,897.08
Exceptional Items Before Tax	0.00	-63.83	0.00	0.00	-12.78
Profit Before Extraordinary Items and Tax	2,303.54	1,594.13	1,326.99	1,753.37	1,884.30
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	2,303.54	1,594.13	1,326.99	1,753.37	1,884.30
Taxation	213.82	33.62	192.52	212.12	199.22
Current Tax	350.13	233.02	227.52	303.82	331.83
MAT Credit Entitlement	-89.03	-200.20	0.00	0.00	0.00
Deferred Tax	-47.28	0.80	-35.00	-91.70	-132.61
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	2,089.72	1,560.51	1,134.47	1,541.25	1,685.08
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	191.17	186.64	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	293.85	286.90	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	-102.68	-100.26	0.00	0.00	0.00
Profit Attributable to Shareholders	2,280.89	1,747.15	1,134.47	1,541.25	1,685.08
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	2,280.89	1,747.15	1,134.47	1,541.25	1,685.08
Earning Per Share - Basic	190.77	146.13	94.88	128.90	140.93
Earning Per Share - Diluted	190.77	146.13	94.88	128.90	140.93
Operation Profit before Depreciation	2,663.26	1,977.17	1,643.24	2,010.25	2,138.94
Operating Profit after Depreciation	2,379.65	1,738.03	1,413.39	1,791.27	1,940.01
Dividend Per Share	45.00	40.00	50.00	34.00	30.00
Dividend Percentage	2,250.00	2,000.00	2,500.00	1,700.00	1,500.00
Equity Dividend	538.04	478.26	597.83	406.52	358.70
Weighted Average Shares - Basic	11.96	11.96	11.96	11.96	11.96
Weighted Average Shares - Diluted	11.96	11.96	11.96	11.96	11.96